This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Trends Redefining Beauty: What to Expect in 2024
by Ansuiya Mohta
Inter Parfums (IPAR), COTY, European Wax Center (EWCZ) and Olaplex (OLPX) are well-positioned to continue their growth story in 2024, backed by solid brand images and innovation efforts.
COTY Gains From Solid Beauty Product Business Amid Headwinds
by Zacks Equity Research
COTY gains from strength across its businesses, strategic priorities and cost optimization programs. However, it has been grappling with rising operating costs and expenses.
Here's How Innovation Keeps Colgate (CL) Stock on Growth Track
by Zacks Equity Research
Colgate (CL) has been reaping the benefits of innovation, bold pricing actions, accelerated revenue growth management strategies and efficient execution.
Newell (NWL) Keen on Restructuring & Cost Savings: Stock to Gain
by Zacks Equity Research
Newell (NWL) looks poised for long-term growth on its recently announced restructuring and cost-saving plans. Near-term headwinds related to tough macro conditions and inflation are concerning.
Product Launches Aid Inter Parfums (IPAR), High Costs Ail
by Zacks Equity Research
Inter Parfums (IPAR) is witnessing increased market share owing to new product launches and brand extensions. However, rising SG&A expenses are a concern.
Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Coty, Inter Parfums, e.l.f. Beauty and European Wax Center
by Zacks Equity Research
Coty, Inter Parfums, e.l.f. Beauty and European Wax Center have been highlighted in this Industry Outlook article.
4 Cosmetics Stocks Worth Watching Amid Industry Headwinds
by Ansuiya Mohta
The Zacks Cosmetics industry is facing rising costs and supply-chain-related issues. Focus on digital business and innovations is aiding Coty, e.l.f. Beauty (ELF), Inter Parfums (IPAR) and European Wax Center (EWCZ).
COTY Benefits From its Business Strength, Headwinds Persist
by Zacks Equity Research
COTY benefits from solid momentum in its businesses and cost optimization programs. However, it has been witnessing rising operating costs and expenses.
Inter Parfums (IPAR) Expects Sales & Earnings Growth in 2024
by Zacks Equity Research
Inter Parfums (IPAR) has been gaining from a solid fragrance market and its focus on innovation. It expects net sales and earnings per share to grow year over year in 2024.
Inter Parfums (IPAR) Gains on Solid Brands & Product Launches
by Zacks Equity Research
Inter Parfums (IPAR) appears well-positioned in the booming fragrance market, courtesy of a solid brand portfolio and innovations.
Tyson Foods (TSN) Q4 Earnings Beat Estimates, Sales Dip Y/Y
by Zacks Equity Research
Tyson Foods (TSN) posts soft sales results in fourth-quarter fiscal 2023 owing to a decline in sales across all its segments.
Wall Street Analysts Predict a 37.73% Upside in Inter Parfums (IPAR): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 37.7% in Inter Parfums (IPAR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Inter Parfums (IPAR) Beats on Q3 Earnings, Ups FY23 EPS View
by Zacks Equity Research
Inter Parfums' (IPAR) robust Q3 performance positions it for continued success, with a strategic focus on innovation, market expansion and prudent financial management in the fragrance industry.
COTY Raises FY24 Revenue Outlook Despite Q1 Earnings Miss
by Zacks Equity Research
COTY's first-quarter fiscal 2024 results reflect improved sales on gains from the Prestige & Consumer Beauty business. However, earnings decline year over year.
Inter Parfums (IPAR) Q3 Earnings Beat Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of 30.71% and 0.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Purple Innovation (PRPL) Q3 Earnings Coming Up: What to Expect
by Zacks Equity Research
Purple Innovation's (PRPL) third-quarter 2023 sales results are likely to reflect gains from the innovative product line, brand development and expansion initiatives.
Flowers Foods (FLO) Queues for Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Flowers Foods' (FLO) third-quarter results are likely to reflect gains from the company's brand-focused strategy and pricing amid elevated costs.
Inter Parfums (IPAR) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Inter Parfums' (IPAR) third-quarter 2023 performance will likely reflect gains from the company's brand strength. However, rising SG&A expenses are a concern.
What to Note Ahead of Hain Celestial's (HAIN) Q1 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) first-quarter fiscal 2024 performance is anticipated to reflect the adverse impacts of weakness in the North America segment and industry-wide supply constraints.
Beyond Meat (BYND) Announces Preliminary Results for Q3
by Zacks Equity Research
Beyond Meat's (BYND) third-quarter 2023 preliminary results suggest revenue declines of 9% and 26.5% on a year-over-year and sequential basis, respectively. Provides updates on its cost-saving actions.
COTY Set to Report Q1 Earnings: What Awaits the Stock?
by Zacks Equity Research
COTY's first-quarter results are likely to reflect gains across the Prestige and Consumer Beauty businesses. A focus on core priorities has been working well for Coty.
Pricing Aids Clorox's (CLX) Q1 Earnings Amid Cyberattack Woes
by Zacks Equity Research
Clorox's (CLX) Q1 results reflect the impacts of lower volume due to the recent cyberattack. However, results are largely offset by its pricing actions and cost-saving initiatives.
Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance
by Zacks Equity Research
Nu Skin (NUS) faces challenging y/y comparisons and macroeconomic hurdles in Q3, leading to a downward revision in its revenue and EPS projections for 2023.
Service Corporation (SCI) Q3 Earnings Beat, Sales Rise Y/Y
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2023 results reflect increased earnings and sales on growth across both segments.